NanoLogix, Inc.
OTC: NNLX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bret T. Barnhizer
- Employees
- 7
- Headquarters
- Hubbard, United States
- IPO year
- 2009
- Market cap
- $12.0K
- Website
- https://nanologix.com
Loading NNLX…
Loading profile data…Frequently asked questions about NNLX
What does NanoLogix, Inc. (NNLX) do?
NanoLogix, Inc., a biotechnology firm, specializes in developing and providing rapid diagnostic and live cell test kits. These kits are designed to accurately detect viable bacteria and a wide array of other microorganisms. Among its key offerings are the BioNanoPore kit, which utilizes a unique water-permeable membrane capable of interacting wi...
Where does NNLX trade?
NanoLogix, Inc. (NNLX) trades on the Other OTC.
What sector is NNLX in?
NanoLogix, Inc. (NNLX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NanoLogix, Inc.?
Bret T. Barnhizer is the chief executive officer of NanoLogix, Inc. (NNLX).
Where is NanoLogix, Inc. headquartered?
NanoLogix, Inc. is headquartered in United States.
Does NNLX pay a dividend?
NanoLogix, Inc. (NNLX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NNLX go public?
NanoLogix, Inc. (NNLX) completed its initial public offering in 2009.